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In 2015, BMC launched Clinical Diabetes and Endocrin-
ology (CDE), a peer reviewed, open access academic jour-
nal dedicated to improving the care of people affected
by diabetes and endocrine disorders. The University of
Michigan’s Division of Metabolism, Endocrinology &
Diabetes has been a partner in this journal since its incep-
tion, and has a longstanding commitment to advancing
global interest in diabetes and endocrinology, as both
Maturity Onset Diabetes of the Young (MODY) by Dr.
Stefan Fajans [1] and Primary Aldosteronism by Dr. Jerome
Conn [2] were both first described at Michigan. National
and international collaborations including Michigan and
multiple other outstanding academic centers have led to
important contributions to the fields of GI hormones,
Cushing’s syndrome, CNS control of the gonadal axis,
obesity and insulin resistance, endocrine oncology, diabetes
clinical practice, and more.
CDE was launched under the leadership of Dr. Meng
H Tan as the inaugural Editor-in-Chief along with Editor-
ial Board members from 19 nations in 5 continents. Thus
far, the journal has published articles that have covered
many important aspects of diabetes mellitus, thyroid, pitu-
itary, and adrenal disorders, bone health, dyslipidemias,
podiatry, diabetes education, peer-support, depression and
lipodystrophy research, from case reports to clinical trials.
Some of the most highly accessed articles in CDE provide
clinicians with an overview of the literature on specific
topics and improve their ability to handle these situations;
these include
 Management of diabetes mellitus in patients with
chronic kidney disease [3]
 Managing diabetes in the digital age [4]
 Thyroid nodule update on diagnosis and
management [5]
 Hypophysitis: Evaluation and Management [6]
In July 2017, CDE reached its first major milestone,
becoming indexed in PubMed; we’ve since seen the
number of accesses to its published manuscripts steadily
increase.
Given Dr. Tan’s impending retirement in July 2018, we
are delighted to announce the passing of the torch to
two new co-Editors-in-Chief: Drs. Ariel Barkan and
Roma Gianchandani. Both are well-published clinician
scientists who have served on the CDE Editorial Board
from the beginning. Additionally, Dr. Tan will continue
on at CDE as Editor Emeritus.
Both Drs. Barkan and Gianchandani are excited and
enthusiastic about the future of CDE:
‘This is a unique and exciting time in diabetes and
endocrinology with unprecedented number of innovations
in medications, technology and big data. We feel
fortunate to be co-Editors-in-Chief of an open access
platform with the ability to share these discoveries
with colleagues around the world and improve patient
care. We welcome comments and suggestions about the
direction of this journal.”
Going forward, CDE intends to open its pages, inviting
colleagues from around the world to share their new
knowledge and findings related to diabetes and endocrine
diseases via our platform. We encourage submissions
from colleagues at national and international diabetes/
endocrinology centers as well as other specialties that
have innovative studies related to diabetes and endocrin-
ology. Cross-pollination and collaboration of ideas is the
direction of medicine today. Together with our global
Editorial Board members and a streamlined and well-
organized review process, CDE intends to grow and
make a significant contribution to the world of diabetes
and endocrinology.
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